Skip to content

CT-based Radiomic Signature Can Identify Adenocarcinoma Lung Tumor Histology

CT-based Radiomic Signature Can Identify Adenocarcinoma Lung Tumor Histology

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03940846
Enrollment
650
Registered
2019-05-07
Start date
2019-03-01
Completion date
2021-01-31
Last updated
2020-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonsmall Cell Lung Cancer

Brief summary

Lung cancer remains the leading cause of cancer related mortality worldwide, with more than 1.5 million related deaths annually. Lung cancer is divided into two main groups: Small Cell Lung Carcinoma (SCLC) and Non-Small Cell Lung Carcinoma (NSCLC), with prevalence of \ 20% and 80% respectively. NSCLC is further subdivided into adenocarcinoma (the most common), squamous cell carcinoma (SCC), and large cell carcinoma. Furthermore, each subtype is likely to have specific mutations, which could be targeted for treatment. Medical imaging and radiomics feature extraction represent a candidate alternative to conventional tissue biopsy, a theory that is investigated in this study.

Interventions

DIAGNOSTIC_TESTVirtual biopsy

Radiomics -the high throughput extraction of quantitative features from medical imaging- extract features that might potentially decode biologic tumor information, which might ultimately reduce the need to use invasive procedure, such as tissue biopsy.

Sponsors

University of California, San Francisco
CollaboratorOTHER
Radboud University Medical Center
CollaboratorOTHER
Maastricht University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Availability of diagnostic non-contrast enhanced CT scan. * Availability of histologic tumor analysis results

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Lung histologyDecember 2019Is the tumor under investigation an adenocarcinoma of the lung?

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026